United States · Health Care · USD (Millions) · Annual
Key financials
USD|Millions
ROE
-117.16%
2025 (actual)
ROA
32.17%
2025 (actual)
Gross Margin
93.5%
2025 (actual)
Net Margin
39.19%
2025 (actual)
Total Assets
$1,176.51M
2025 (actual)
Net Income
$440.30M
2025 (actual)
Valuation
$1,108.44M
2026 (forecast)
Stock Price
$6.72
Historical & projected performance
USD|Millions
Reported figures and Equlion model projections for the next 5 years.
ROE
+140 pt
Company
Sector average
ROA
-48 pt
Company
Gross Margin
-24.8 pt
Company
Sector average
Net Margin
-87.4 pt
Company
Total Assets
+17%
Company
Sector average (own scale)
Net Income
-148%
Company
Valuation
+105.2%
Company
Sector average (own scale)
Stock Price
+105.2%
Company
Amounts in USD (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for NOVAVAX INC? It covers the balance sheet, income statement, cash flow and Equlion model projections.